Long-term Impact Study for COVID-19 in Children
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how COVID-19 affects children and young adults over time, focusing on those with long-term symptoms, often called "long COVID." Researchers will observe both individuals who have had COVID-19 and those who haven't to identify risk factors and occurrences of post-acute sequelae of SARS-CoV-2 (PASC), which are ongoing symptoms after the initial infection. Participants may include children or young adults aged 0-25 who have had COVID-19 in the past two years, have been exposed to the virus, or live in areas with high transmission. This includes those with frequent COVID-19 symptoms or those who have been vaccinated. The study will collect health data and biological samples to track the virus's long-term health impacts. As an unphased study, this trial offers participants a chance to contribute to vital research that could improve understanding and treatment of long COVID in young populations.
Do I have to stop taking my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
Why are researchers excited about this trial?
Researchers are excited about this trial because it aims to uncover the long-term effects of COVID-19 on children and families. Unlike immediate treatment options that focus on symptom management or virus mitigation, this observational study seeks to understand the broader, lasting impacts of the virus. By identifying these long-term effects, the study could potentially guide future healthcare strategies and interventions, ensuring better mental, physical, and social health outcomes for children and their families in the post-pandemic world.
Who Is on the Research Team?
Leora Horwitz, MD
Principal Investigator
NYU Langone Health
Stuart Katz, MD, MS
Principal Investigator
NYU Langone Health
Andrea Troxel, ScD
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial data collection including demographics, medical history, and SARS-CoV-2 infection status
Longitudinal Follow-up
Participants are monitored for symptoms and changes in health status over time
Biologic Specimen Collection
Collection of biologic specimens at specified intervals for analysis
What Are the Treatments Tested in This Trial?
Interventions
- Observational Study
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator